Investigation of the Effect of Information on the Empowerment of Cancer Patients Using Question Prompt List: A Mixed Method Study

December 3, 2025 updated by: Asuman Kuscu, Marmara University

Brief Summary The goal of this study is to understand how patient empowerment and a Question Prompt List (QPL) can help cancer patients.

The main questions this study aims to answer are:

What are the views of nurses, physicians, and cancer patients on patient empowerment? Does using a Question Prompt List (QPL) improve patient empowerment and reduce anxiety? Researchers will collect qualitative and quantitative data by measuring patient empowerment and anxiety levels.

Who can participate? Cancer patients receiving treatment at Private Anadolu Medical Center Hospital Nurses and physicians working with cancer patients What will participants do? Answer survey questions about their experiences with empowerment, anxiety, and communication Participate in interviews to share their thoughts on patient empowerment Use a Question Prompt List (QPL) during medical consultations Why is this study important? Many cancer patients struggle with anxiety and lack of information about their care.

A Question Prompt List (QPL) may help patients ask better questions, feel more in control of their treatment, and reduce anxiety.

This study will contribute to oncology research and help develop a culture-specific QPL for use in cancer care.

This study will take place at Private Anadolu Medical Center Hospital from January 2023 to November 2024.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

96

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Kadıköy
      • Istanbul, Kadıköy, Turkey (Türkiye), 34722
        • Marmara Üniversitesi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients must be over 18 years old.
  • Must understand and speak Turkish.
  • Must not have any condition preventing participation (e.g., advanced dementia, cognitive impairment, speech or hearing disorders).
  • For healthcare professionals in the qualitative phase: Must have at least one year of experience in oncology.

Exclusion Criteria:

  • Patients without regular outpatient follow-up visits.
  • Patients with severe cognitive or physiological deterioration affecting participation.
  • Patients who do not comply with the study process and requirements.
  • Patients who voluntarily request to withdraw from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: "QPL vs. standard care to assess impact on patient empowerment & anxiety in cancer patients.

Experimental Group 1 (QPL Communication Intervention Group) Participants in this group will receive a structured communication intervention using the Quick Question List (QPL) during their oncology examinations. The QPL aims to enhance patient empowerment, encourage active participation, and improve communication between patients and healthcare providers. It is designed to help patients express their concerns effectively and engage more actively in their care process.

Intervention:

Implementation of a QPL-based communication strategy in addition to standard oncology care.
Behavioral: QPL-based Communication Intervention

This QPL-based communication intervention stands out with the following key features:

Patient-Centered & Cancer-Specific QPL: The intervention uses a QPL tailored for cancer patients, culturally adapted to enhance empowerment and manage anxiety.

Structured Training & Support: Patients receive training before consultations, with additional guidance for effective QPL use at subsequent visits.

Multiple Assessment Points: The QPL's impact is measured after the first, second, and third consultations, allowing for longitudinal evaluation.

RCT Design: This study is a randomized controlled trial (RCT), comparing the intervention group (QPL) to a control group receiving standard care.

Focus on Empowerment & Anxiety: Unlike prior studies, this intervention focuses on empowering patients and reducing anxiety, with outcomes measured through validated scales (Patient Empowerment Scale and HADS).

These features differentiate this intervention by offering a structured, culturally relevant approach.
No Intervention: Standard Care Group

Participants in this group will receive standard physician-patient communication without any additional intervention. This group serves as a control group to evaluate the effectiveness of the QPL-based communication intervention.

Intervention:

No additional communication tools or interventions will be applied. Patients will receive routine oncology consultations with standard physician-patient interactions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Patient Empowerment Score
Time Frame: Immediately before the first consultation and within 1 day after the second and third consultations
Assessed using the Patient Empowerment Scale to evaluate the effect of QPL-based communication on patient empowerment compared to standard communication. Higher scores indicate greater empowerment.
Immediately before the first consultation and within 1 day after the second and third consultations
Change in Anxiety Level (HADS)
Time Frame: Immediately before the first consultation and within 1 day after the second and third consultations
Measured using the Hospital Anxiety and Depression Scale (HADS) to assess changes in anxiety levels resulting from QPL-based communication versus standard communication. Lower scores indicate lower anxiety.
Immediately before the first consultation and within 1 day after the second and third consultations

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Marmara University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2024

Primary Completion (Actual)

March 1, 2025

Study Completion (Actual)

March 1, 2025

Study Registration Dates

First Submitted

March 19, 2025

First Submitted That Met QC Criteria

March 24, 2025

First Posted (Actual)

March 30, 2025

Study Record Updates

Last Update Posted (Actual)

December 10, 2025

Last Update Submitted That Met QC Criteria

December 3, 2025

Last Verified

March 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 09.2022.953

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety

Clinical Trials on QPL-based Communication Intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe